aniline has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, X; Huang, L; Li, W; Li, Y; Tang, Q; Wang, G; Wu, Z; Zhan, Z; Zhang, Y | 1 |
| Liu, K; Ma, X; Shu, X; Sun, Y; Wang, C; Wang, Q; Wu, B; Zhen, Y; Zhou, Y; Zhu, X | 1 |
| Pujol, MD; Romero, M; Vázquez, MT | 1 |
3 other study(ies) available for aniline and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A Novel Aniline Derivative from
Topics: Aniline Compounds; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Molecular Docking Simulation; Peganum; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2023 |
Novel Quinazoline Derivatives Bearing Various 4-Aniline Moieties as Potent EGFR Inhibitors with Enhanced Activity Against NSCLC Cell Lines.
Topics: Aniline Compounds; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Quinazolines; Spectrometry, Mass, Electrospray Ionization | 2016 |
Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
Topics: Aniline Compounds; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Leukemia; Lung Neoplasms; Quinolines; Sensitivity and Specificity; Structure-Activity Relationship | 2004 |